重大事件
外國發行人報告
6-K
2026-07-15
Auna 公佈 2026 年第二季初步KPI，墨西哥化療次數大增85.6%
AI 繁中摘要
Auna 公佈 2026 年第二季度初步關鍵績效指標（KPI）📊
申報類型：6-K（根據 1934 年證券交易法提交的外國私人發行人報告）
拉丁美洲醫療保健服務平台 Auna（總部：盧森堡）於 2026 年 7 月 15 日公佈了截至 2026 年 6 月 30 日的第二季度初步營運數據。該公司在墨西哥、秘魯和哥倫比亞均有業務。以下為各市場主要指標的同比變化（與 2025 年第二季度相比）：
**墨西哥** 🇲🇽
- 急診次數：7,892 次（按年略跌 3.4%）
- 手術次數：5,193 次（增 5.9%）
- 住院日數：25,169 日（增 1.5%）
- 產能使用率：39.1%（2Q'25 為 38.5%）
- 化療及放療次數：4,994 次（大增 85.6%）
**秘魯** 🇵🇪
- 急診次數：51,769 次（增 8.7%）
- 手術次數：5,552 次（增 2.1%）
- 住院日數：28,395 日（增 10.1%）
- 產能使用率：80.2%（2Q'25 為 73.6%）
- 化療及放療次數：12,957 次（跌 3.5%，但仍高於 1Q'26）
- OncoSalud 計劃會員人數：147.2 萬（增 6.0%）
**哥倫比亞** 🇨🇴
- 急診次數：38,196 次（增 5.9%）
- 手術次數：11,167 次（增 6.5%）
- 住院日數：81,558 日（增 3.8%）
- 產能使用率：79.2%（2Q'25 為 76.4%）
- 受保生命（風險分擔協議）：314.4 萬人（增 26.2%）
- 化療及放療次數：39,628 次（增 16.8%）
**摘要重點**：
- 各市場住院及手術量普遍增長，反映疫情後醫療需求持續恢復。
- 化療/放療服務大幅擴張（墨西哥 +85.6%，哥倫比亞 +16.8%），顯示腫瘤業務擴張。
- 秘魯產能利用率突破 80%，哥倫比亞亦接近 80%，營運效率提升。
- OncoSalud 會員及哥倫比亞受保生命顯著增加，反映保險業務滲透率提高。
**管理層展望**：
是次為初步數據，最終第二季度 KPI 可能有修訂。公司表示會每季公佈 KPI，以提高投資者透明度。管理層未提供具體財務數字或全年預測，但強調業務增長趨勢。
**對投資者的潛在影響**：
- 正面訊號：所有市場的住院/手術/腫瘤服務均見
展開英文正文
EX-99.1 2 dp250077_ex9901.htm EXHIBIT 99.1 Exhibit 99.1 Auna Reports Preliminary Key Performance Indicators for the Second Quarter ended June 30, 2026 Luxembourg, July 15, 2026 – Auna S.A. (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today reported select operating metrics for the Second Quarter ended June 30, 2026. The Company publishes these key performance indicators on a quarterly basis as part of its commitment to providing investors with more information and a clearer understanding of Auna. Auna Preliminary Key Performance Indicators As of second quarter ended June 30, 2026 Healthcare Services Mexico Key Operating Metrics 2Q'25 3Q'25 4Q'25 1Q'26 2Q'26 Emergency treatments (1) # 8,170 7,274 8,002 7,864 7,892 Surgeries (2) # 4,904 5,177 5,028 4,855 5,193 Total number of days hospitalized (3) # 24,791 25,450 24,156 25,122 25,169 Total Capacity Utilization (4) % 38.5% 39.1% 37.1% 39.4% 39.1% Chemotherapies & Radiotherapies (sessions) (5) # 2,690 3,678 3,983 4,162 4,994 Healthcare Services Peru Key Operating Metrics 2Q'25 3Q'25 4Q'25 1Q'26 2Q'26 Emergency treatments (1) # 47,602 49,049 47,885 45,485 51,769 Surgeries (2) # 5,438 5,034 4,973 5,851 5,552 Total number of days hospitalized (3) # 25,789 26,912 26,486 26,428 28,395 Total Capacity Utilization (4) % 73.6% 76.0% 74.8% 75.5% 80.2% Chemotherapies & Radiotherapies (sessions) (5) # 13,431 11,622 12,909 13,371 12,957 OncoSalud Peru Key Operating Metrics 2Q'25 3Q'25 4Q'25 1Q'26 2Q'26 Plan Memberships (6) # 1,388,579 1,395,509 1,424,695 1,439,781 1,472,019 Healthcare Services Colombia Key Operating Metrics 2Q'25 3Q'25 4Q'25 1Q'26 2Q'26 Emergency treatments (1) # 36,052 37,323 35,289 38,077 38,196 Surgeries (2) # 10,484 11,209 10,443 10,904 11,167 Total number of days hospitalized (3) # 78,583 80,176 79,349 80,716 81,558 Total Capacity Utilization (4) % 76.4% 77.1% 76.3% 79.3% 79.2% Protected lives (7) # 2,491,218 3,027,499 3,036,335 3,057,763 3,143,694 Chemotherapies & Radiotherapies (sessions) (5) # 33,912 36,668 35,941 36,619 39,628 1) Emergency care includes the number of visits to the emergency rooms and may include several visits per patient. 2) Number of surgeries includes surgeries, outpatient surgeries and cesarean sections. 3) Total number of days during which any of Auna's beds were occupied by a hospitalized patient during the period, including ICU. 4) Total capacity utilization is calculated as (i) (x) total number of days in which any of Auna's beds had a hospitalized patient during the period divided by (y) total number of beds, times (ii) total number of days during the period. 5) Intravenous chemotherapy and radiotherapy infusions in both inpatient and outpatient care; excludes oral treatments. In Peru, includes sessions across the Healthcare Services Network and OncoSalud Segments. 6) As of period end and as reported to the National Superintendence of Health Susalud in Peru. 7) Insured population assigned to Auna under risk-sharing agreements in Colombia. About Auna Auna is one of Latin America’s leading healthcare platforms, with operations in Mexico, Peru, and Colombia. It prioritizes prevention and focuses on complex diseases that represent the highest healthcare spending. Its mission is to transform healthcare by delivering access to a highly integrated offering of services in low-penetration markets across Spanish-speaking Latin America. Founded in 1989, Auna has built one of the region’s largest modern healthcare platforms, consisting of a horizontally integrated network of medical care centers and a vertically integrated portfolio of oncology and general health plans. As of June 30, 2026, Auna’s network included 31 healthcare facilities—hospitals, ambulatory centers, and prevention and wellness centers—with a total of 2,337 beds and 1.4 million health plan members. Contact [email protected] Preliminary Information The information contained in this press release is preliminary in nature and is provided for informational purposes only. It is based on current estimates, assumptions, and expectations, which remain subject to ongoing review, verification, and possible revision. Final second quarter ended June 30, 2026 Key Performance Indicators may differ from those set forth herein. Readers are cautioned not to place undue reliance on these preliminary results. Cautionary Statement on Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often are proceeded by words such as “believes,” “expects,” “may,” “anticipates,” “plans,” “intends,” “assumes,” “will” or similar expressions. The forward-looking statements contained herein include statements about our intention to publish these key performance indicators on a quarterly basis. These expectations may or may not be realized. Some of these expectations may be based upon assumptions or judgments that prove to be incorrect. In addition, Auna’s business and operations involve numerous risks and uncertainties, many of which are beyond the control of Auna, which could result in Auna’s expectations not being realized or otherwise materially affect the financial condition, results of operations and cash flows of Auna. Some of the factors that could cause future results to materially differ from recent results or those projected in forward-looking statements are described in Auna’s filings with the United States Securities and Exchange Commission, including its annual report filed on Form 20-F on April 22, 2026. The forward-looking statements are made only as of the date hereof, and Auna does not undertake any obligation to (and expressly disclaims any obligation to) update any forward-looking statements to reflect events or circumstances after the date such statements were made, or to reflect the occurrence of unanticipated events. In light of the risks and uncertainties described above, and the potential for variation of actual results from the assumptions on which certain of such forward-looking statements are based, investors should keep in mind that the results, events or developments disclosed in any forward-looking statement made in this document may not occur, and that actual results may vary materially from those described herein, including those described as anticipated, expected, targeted, projected or otherwise. 2